MarketInOut Stock Screener Log In | Sign Up

BioNexus Gene Lab Corp

NASDAQ • Basic Materials • Specialty Chemicals • Quote as of 10/30/2026
BioNexus Gene Lab Corp stock price and volume chart

Company Profile

IndustrySpecialty Chemicals
SectorBasic Materials
ExchangeNASDAQ
Market Capitalization3.31 mln
Float1.56 mln
Earnings Date11/13/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-4.49
Highly reliable

Relative Strength

9 / 100
Severely lagging

Debt / Equity

0.03
Debt-free

Pre-Tax Margin

-82%
Severely loss-making

ROE

-33.16
Deeply negative

Business Description

BioNexus Gene Lab Corp. is a Malaysia-based company founded in 2017 that sells chemical raw materials to manufacturers of medical, industrial, automotive, and electronic products across Southeast Asia. Its chemicals are used to make items such as handrails, clean room panels, boat hulls, and aerospace components. The company also offers non-invasive blood-based tests designed to detect early signs of disease through biomarker analysis.

Key Fundamentals

EPS-1.29
ROE-33.16
RPS1.44
ROIC-38.75
ROA-22.90
Interest Cover-407
EBITDA, mln-2.38
EV / EBITDA-0.04
Revenue, mln3.13
EV / Revenue0.04

Quote Details

Last 0.9175
Change -0.0625 (-6.38%)
Open 0.925
Volume 7,360
Turnover 6,752.8
Average Volume 5,696.62

Financial Ratios

Pre-Tax Profit Margin-82
Leverage Ratio1.12
Current Ratio6.08
Price / Book0.35
Price / Tangible Book0.35
Debt / Equity0.03
Price / Sales0.66

Financial Strength

Altman Z-Score0.89
Piotroski F-Score 3 / 9
Beneish M-Score-4.49
Short Ratio0.92
Short % of Float0.36

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -22.9% 6 / 100   
1 Month -23.54% 19 / 100   
2 Months -40.42% 13 / 100   
6 Months -55.46% 12 / 100   
1 Year -81.97% 6 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog